Immunocytochemistry for SOX ‐11 and TFE3 as diagnostic markers for solid pseudopapillary neoplasms of the pancreas in FNA biopsies
CONCLUSIONSSOX‐11 is a sensitive and specific immunocytochemical stain for SPNs in EUS‐FNA specimens, and it may be useful as a diagnostic marker for distinguishing SPNs from its cytologic mimics. Cancer Cytopathol 2017. © 2017 American Cancer Society. (Source: Cancer Cytopathology)
Source: Cancer Cytopathology - October 1, 2017 Category: Pathology Authors: Wen ‐Chi Foo, Grant Harrison, Xuefeng Zhang Tags: Original Article Source Type: research
Preparing our next generation of pathologists: The criticality of critical reading
(Source: Cancer Cytopathology)
Source: Cancer Cytopathology - September 20, 2017 Category: Pathology Authors: Lananh N. Nguyen, W. Tony Parks Tags: Bridging the Gap Source Type: research
The art of caring
(Source: Cancer Cytopathology)
Source: Cancer Cytopathology - September 15, 2017 Category: Pathology Authors: Bryn Nelson Tags: CytoSource Source Type: research
Issue Information
(Source: Cancer Cytopathology)
Source: Cancer Cytopathology - September 15, 2017 Category: Pathology Tags: Issue Information Source Type: research
Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary ‐like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules
CONCLUSIONSIn indeterminate FNA specimens, the distinction of a possible NIFTP from a benign thyroid nodule can be suggested using a simple nuclear scoring system that is most valuable in AUS aspirates. Cancer Cytopathol 2017. © 2017 American Cancer Society. (Source: Cancer Cytopathology)
Source: Cancer Cytopathology - September 15, 2017 Category: Pathology Authors: Kyle C. Strickland, Brooke E. Howitt, Justine A. Barletta, Edmund S. Cibas, Jeffrey F. Krane Tags: Original Article Source Type: research
A modified reporting approach for thyroid FNA in the NIFTP era: A 1 ‐year institutional experience
CONCLUSIONSThyroid FNA reporting modifications due to NIFTP affect only a small subset of specimens. When NIFTP is suspected, an explanatory note promotes limited surgical excision. More stringent criteria for malignancy affect few cases while potentially limiting false‐positive diagnosis due to NIFTP. Cancer Cytopathol 2017. © 2017 American Cancer Society. (Source: Cancer Cytopathology)
Source: Cancer Cytopathology - September 13, 2017 Category: Pathology Authors: Jeffrey K. Mito, Erik K. Alexander, Trevor E. Angell, Justine A. Barletta, Matthew A. Nehs, Edmund S. Cibas, Jeffrey F. Krane Tags: Original Article Source Type: research
Costs of ALK, ROS1, EGFR, and KRAS testing in non –small cell lung cancer: About different strategies in France
(Source: Cancer Cytopathology)
Source: Cancer Cytopathology - September 11, 2017 Category: Pathology Authors: Laetitia Lambros, Briac Guibourg, Arnaud Uguen Tags: Correspondence Source Type: research
Histopathologic follow ‐up and HPV test results with HSIL Papanicolaou test results in China's largest academic women's hospital
CONCLUSIONSAt OGHFU, the finding of an increase in HSIL cytology rates with increasing patient age contrasted with a finding of decreasing HSIL rates with increasing age previously reported in regularly screened cotested patients in the United States. The increasing HSIL rates with older age and high rates of cervical cancer diagnoses noted at OGHFU appear to be best explained by the absence of consistent intraepithelial lesion ablation achievable with frequent screening and treatment. Cancer Cytopathol 2017. © 2017 American Cancer Society. (Source: Cancer Cytopathology)
Source: Cancer Cytopathology - September 8, 2017 Category: Pathology Authors: Xiang Tao, R. Marshall Austin, Hao Zhang, Lihong Zhang, Jianan Xiao, Xianrong Zhou, Li Wang, Chengquan Zhao Tags: Original Article Source Type: research
Programmed death ‐ligand 1 expression in non‐small cell lung carcinoma: Comparison among cytology, small biopsy, and surgical resection specimens
CONCLUSIONSQuantification of PD‐L1 expression is feasible on cytology specimens, and the results are comparable to those obtained from surgical resection and small biopsy specimens, including in matched specimens and using a single predictive IHC marker. Future studies will be necessary to determine the comparative value of other antibodies and their ability to predict response to immunotherapy. Cancer Cytopathol 2017. © 2017 American Cancer Society. (Source: Cancer Cytopathology)
Source: Cancer Cytopathology - September 1, 2017 Category: Pathology Authors: Jonas J. Heymann, William A. Bulman, David Swinarski, Carlos A. Pagan, John P. Crapanzano, Mehrvash Haghighi, Ladan Fazlollahi, Mark B. Stoopler, Joshua R. Sonett, Adrian G. Sacher, Catherine A. Shu, Naiyer A. Rizvi, Anjali Saqi Tags: Original Article Source Type: research
GATA3 is a reliable marker for neuroblastoma in limited samples, including FNA Cell Blocks, core biopsies, and touch imprints
CONCLUSIONSGATA3 is a reliable diagnostic marker for NBs not only in scant/limited surgical specimens but also in cytologic samples, including air‐dried touch imprints, which have previously been undescribed for this marker. Cancer (Cancer Cytopathol) 2017. © 2017 American Cancer Society. (Source: Cancer Cytopathology)
Source: Cancer Cytopathology - September 1, 2017 Category: Pathology Authors: Austin Blackburn Wiles, Jeremiah Xavier Karrs, Susan Pitt, Jorge Almenara, Celeste N. Powers, Steven Christopher Smith Tags: Original Article Source Type: research
Application of microscope ‐based scanning software (Panoptiq) for the interpretation of cervicovaginal cytology specimens
CONCLUSIONSPanoptiq appears to be feasible for the interpretation of cervicovaginal cytology specimens but requires adequate training in digital pathology. Cancer Cytopathol 2017. © 2017 American Cancer Society. (Source: Cancer Cytopathology)
Source: Cancer Cytopathology - September 1, 2017 Category: Pathology Authors: Ruben Groen, Kuniko Abe, Han ‐Seung Yoon, Zaibo Li, Rulong Shen, Akira Yoshikawa, Takao Nitanda, Yukiko Shimizu, Isao Otsuka, Junya Fukuoka Tags: Original Article Source Type: research
Noninvasive follicular thyroid neoplasm with papillary ‐like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)
CONCLUSIONSThe institutional frequency of NIFTP histopathology diagnosis and cytology baseline data will impact the ROM associated with specific FNAC diagnoses, especially among the indeterminate TBSRTC categories. The range of ROM for each TBSRTC diagnostic category is reflective of the inherent diagnostic thresholds and interobserver and interinstitutional variability in the diagnosis of thyroid lesions. Cancer Cytopathol 2017. © 2017 American Cancer Society. (Source: Cancer Cytopathology)
Source: Cancer Cytopathology - September 1, 2017 Category: Pathology Authors: Haijun Zhou, Zubair W. Baloch, Ritu Nayar, Tommaso Bizzarro, Guido Fadda, Deepti Adhikari ‐Guragain, Joseph Hatem, Luigi M. Larocca, Julia Samolczyk, Jamie Slade, Esther Diana Rossi Tags: Original Article Source Type: research
Determination of PD ‐L1 expression in effusions from mesothelioma by immuno‐cytochemical staining
CONCLUSIONMM effusions are suitable for immune‐cytochemical assessment of PD‐L1 expression in malignant cells and the results are similar to those reported for histological specimens. Cancer Cytopathol 2017. © 2017 American Cancer Society. (Source: Cancer Cytopathology)
Source: Cancer Cytopathology - September 1, 2017 Category: Pathology Authors: Mohammed S. I. Mansour, Tomas Seidal, Ulrich Mager, Amir Baigi, Katalin Dobra, Annika Dejmek Tags: Original Article Source Type: research
FNA cytology of solitary fibrous tumors and the diagnostic value of STAT6 immunocytochemistry
CONCLUSIONSBenign and malignant SFTs have common cytopathologic features, and the ability to distinguish between them is limited. Nuclear STAT6 immunoreactivity is a valuable cytologic marker for SFTs. Cancer Cytopathol 2017. © 2017 American Cancer Society. (Source: Cancer Cytopathology)
Source: Cancer Cytopathology - September 1, 2017 Category: Pathology Authors: Edneia Tani, Johan Wejde, Kristina Åström, Inga‐Lill Wingmo, Olle Larsson, Felix Haglund Tags: Original Article Source Type: research
Primum Non Nocere
In a 15‐year follow‐up study based on the presence and numbers of circulating tumor cells and tumor DNA before, immediately after, and at defined points after core‐needle and fine‐needle biopsy procedures, a strong case is made for revisiting and potentially changing current practice to include fine‐needle biopsy as the initial biopsy procedure in patients with breast masses. See also pages 000‐000. (Source: Cancer Cytopathology)
Source: Cancer Cytopathology - August 24, 2017 Category: Pathology Authors: Miguel A. Sanchez, Ana M. Burga, Britt Marie Ljung Tags: Editorial Source Type: research
